HUM - NYSE

Humana Inc.

HUM·NYSE

$327.54

-0.31%

HealthcareMedical - Healthcare Plans

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$39.32B

EPS9.8700

P/E Ratio33.19

Earnings Date07/29/2026

48.75B

Assets

3Y+11.0%

5Y+39.0%

10Y+92.0%

31.01B

Total Liabilities

3Y+9.0%

5Y+46.0%

10Y+111.0%

17.74B

Total Equity

3Y+15.0%

5Y+29.0%

10Y+66.0%

Humana Inc. Funding & Solvency Profile

HUM · NYSE

Current Assets

Cash & Cash Equivalents4.20B

Net Receivables3.27B

Inventory0.00

Other Current Assets0.00

Total Current Assets7 B

Non-Current Assets

Property, Plant & Equipment2.72B

Goodwill & Intangible Assets10.81B

Long-Term Investments16.83B

Other Non-Current Assets10.83B

Total Non-Current Assets30 B

Total Assets

48.75B

Financial Health Analysis

Current Ratio

0.72x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

1.75x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

-2844000000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

15% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

Humana Inc. Balance Sheet

HUM • NYSE

Humana Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	4.2B	2.2B	4.7B	5.1B	3.4B	4.7B	4.1B	2.3B	4B	3.9B	2.6B	1.9B	1.1B	1.3B	1.4B	1.7B	1.6B	2B	2B	1.7B
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	11B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7B	6.9B	6.2B	4.2B	3.6B	3.2B
Cash & Short-Term Investments	4.2B	2.2B	4.7B	5.1B	3.4B	4.7B	15B	2.3B	4B	3.9B	2.6B	1.9B	1.1B	1.3B	9.1B	8.5B	7.8B	6.2B	5.7B	4.9B
Net Receivables	3.3B	2.7B	2B	1.7B	1.8B	1.1B	1.1B	1B	854M	1.3B	1.2B	1.1B	950M	733M	1B	959M	823.6M	789.7M	605.5M	680.9M
Accounts Receivables	3.3B	2.7B	2B	1.7B	1.8B	1.1B	1.1B	1B	854M	1.3B	1.2B	1.1B	950M	733M	1B	959M	811.8M	777.7M	592.8M	667.7M
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8M	12M	12.8M	13.3M
Other Current Assets	0.0	0.0	0.0	0.0	0.0	-18.4B	-16.1B	-1B	-854M	-1.3B	-1.2B	-1.1B	-950M	9.7B	1B	632.8M	625.5M	1.4B	2.5B	1.7B
Total Current Assets	7.5B	4.9B	6.7B	6.7B	5.2B	0.0	0.0	2.3B	4B	3.9B	2.6B	1.9B	1.1B	11.7B	11.2B	10.1B	9.3B	8.4B	8.7B	7.3B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	2.7B	3B	3.5B	3.7B	3.8B	2.8B	2B	1.7B	1.6B	1.5B	1.4B	1.2B	1.2B	1.1B	912M	815.3M	679.1M	711.5M	637.2M	545M
Goodwill	9.7B	9.6B	9.6B	9.1B	11.1B	4.4B	3.9B	3.9B	3.3B	3.3B	3.3B	3.2B	3.7B	3.6B	2.7B	2.6B	2B	2B	1.7B	1.3B
Intangible Assets	1.1B	1.4B	1.7B	1.8B	2.6B	329M	177M	245M	329M	399M	492M	607M	859M	880M	0.0	0.0	0.0	0.0	0.0	0.0
Goodwill & Intangible Assets	10.8B	11.1B	11.2B	10.9B	13.7B	4.8B	4.1B	4.1B	3.6B	3.7B	3.8B	3.8B	4.6B	4.5B	2.7B	2.6B	2B	2B	1.7B	1.3B
Long-Term Investments	16.8B	19.3B	17.7B	15B	14.1B	0.0	12.4B	11.5B	2.7B	2.2B	1.8B	1.9B	1.7B	1.8B	1.7B	1.5B	1.3B	1B	1B	414.9M
Tax Assets	84M	260M	48M	851M	578M	302M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	10.8B	7.7B	7.6B	6.5B	7.4B	-7.9B	-18.5B	17.2B	17.9B	16.3B	17B	16.5B	13.8B	-5.6B	0.0	0.0	0.0	0.0	0.0	0.0
Total Non-Current Assets	41.3B	41.4B	40.2B	37B	39.5B	0.0	0.0	23.1B	23.1B	21.5B	22.1B	21.6B	19.6B	5.6B	0.0	0.0	0.0	0.0	0.0	0.0
Other Assets	0.0	0.0	0.0	0.0	0.0	35B	29.1B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Assets	48.8B	46.3B	46.9B	43.7B	44.7B	35B	29.1B	25.4B	27.2B	25.4B	24.7B	23.5B	20.7B	20B	17.7B	16.1B	14.2B	13B	12.9B	10.1B
LIABILITIES
CURRENT LIABILITIES
Total Payables	9.8B	10.3B	10.1B	9.1B	8.1B	0.0	10B	171M	141M	212M	301M	334M	403M	8B	7.5B	5.2B	4.5B	4.3B	4B	4.7B
Accounts Payable	9.8B	10.3B	10.1B	9.1B	8.1B	0.0	9.8B	0.0	0.0	0.0	0.0	0.0	0.0	7.7B	7.2B	1.7B	1.3B	1.1B	1.3B	0.0
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	225M	171M	141M	212M	301M	334M	403M	324M	306M	3.5B	3.2B	3.2B	2.7B	4.7B
Short Term Debt	150M	724M	1.6B	2.3B	2.1B	0.0	699M	1.7B	150M	300M	299M	0.0	0.0	324M	306M	409.4M	374.5M	224.5M	269.2M	293.6M
Deferred Revenue	356M	260M	266M	286M	254M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.4M	0.0	0.0	0.0	155.3M
Other Current Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	-10.7B	7.9B	9.1B	7B	-964M	-695M	5.7B	-8.3B	-1.8B	-169K	355.2M	676.8M	1.6B	77.9M
Total Current Liabilities	10.3B	11.3B	11.9B	11.6B	10.5B	0.0	0.0	10.1B	9.4B	7.8B	0.0	0.0	6.3B	0.0	6.1B	5.7B	5.3B	5.2B	5.8B	5.2B
NON-CURRENT LIABILITIES
Long Term Debt	12.4B	11.1B	10.2B	9B	10.5B	6.1B	5B	4.4B	4.8B	3.8B	3.8B	3.8B	2.6B	2.6B	1.7B	1.7B	1.7B	1.9B	1.7B	1.3B
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	247M	283M	378M	280M	364M	361M	206M	230M	213M	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	878M	1.3B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	7.9B	7.1B	8B	6.4B	5.8B	15.2B	-5.2B	-4.7B	-5.1B	-4.1B	-4.2B	-4.2B	-2.8B	-2.8B	-1.9B	-1.7B	-1.7B	-1.9B	-1.7B	-1.3B
Total Non-Current Liabilities	20.7B	18.6B	18.6B	16.7B	18.2B	21.2B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	17B	15.3B	17.3B	14.7B	14.3B	13.9B	11.4B	11.1B	9.6B	9.2B	8.4B	8.6B	8.9B	7B
Capital Lease Obligations	418M	392M	444M	456M	546M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	31B	29.9B	30.6B	28.4B	28.6B	21.2B	17B	15.3B	17.3B	14.7B	14.3B	13.9B	11.4B	2.6B	9.6B	9.2B	8.4B	8.6B	8.9B	7.1B
SHAREHOLDERS' EQUITY
Treasury Stock	-14.4B	-14.4B	-13.7B	-12.2B	-10.2B	-9.9B	-8.5B	-7.3B	-6.3B	-3.3B	-3.3B	-2.9B	-2.1B	-1.6B	-1B	-494.4M	-385.9M	-363.1M	-257M	-229.6M
Common Stock	33M	33M	33M	33M	33M	33M	33M	33M	33M	33M	33M	33M	33M	32M	32M	31.7M	31.6M	31.3M	31.1M	30.5M
Additional Paid-In Capital	3.6B	3.5B	3.3B	3.2B	3.1B	2.7B	2.8B	2.5B	2.4B	2.6B	2.5B	2.3B	2.3B	2.1B	1.9B	1.7B	1.7B	1.6B	1.5B	1.4B
Retained Earnings	29.1B	28.3B	27.5B	25.5B	23.1B	20.5B	17.5B	15.1B	13.7B	11.5B	11B	9.9B	8.9B	7.9B	6.8B	5.5B	4.4B	3.4B	2.7B	1.9B
Accumulated Other Comprehensive Income/Loss	-633M	-1.1B	-999M	-1.3B	42M	391M	156M	-159M	19M	-66M	58M	223M	158M	386M	303M	120.6M	42.1M	-175.2M	14M	-13.2M
Total Stockholders' Equity	17.7B	16.4B	16.3B	15.3B	16.1B	13.7B	12B	10.2B	9.8B	10.7B	10.3B	9.6B	9.3B	8.8B	8.1B	6.9B	5.8B	4.5B	4B	3.1B
Total Equity	17.7B	16.4B	16.3B	15.4B	16.1B	13.7B	12B	10.2B	9.8B	10.7B	10.3B	9.6B	9.3B	8.8B	8.1B	6.9B	5.8B	4.5B	4B	3.1B
Minority Interest	80M	70M	56M	59M	23M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	48.8B	46.3B	46.9B	43.7B	44.7B	35B	29.1B	25.4B	27.2B	25.4B	24.7B	23.5B	20.7B	20B	17.7B	16.1B	14.2B	13B	12.9B	10.1B
Total Investments	16.8B	19.3B	17.7B	15B	14.1B	0.0	12.4B	11.5B	2.7B	2.2B	1.8B	1.9B	1.7B	9.8B	9.5B	8.4B	7.5B	5.2B	4.7B	3.6B
Total Debt	12.9B	12.3B	12.3B	11.8B	13.2B	6.1B	5.7B	6.1B	4.9B	4.1B	4.1B	3.8B	2.6B	2.9B	2B	2.1B	2.1B	2.2B	2B	1.6B
Net Debt	8.7B	10B	7.6B	6.7B	9.8B	1.4B	1.6B	3.7B	878M	215M	1.5B	1.9B	1.5B	1.6B	588M	405.1M	439M	191.2M	-83.4M	-177.6M
Shares Outstanding	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068	120,273,068

SEC Filings

HUM - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	June 01, 2026	June 01, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 19, 2026	May 15, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 29, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 29, 2026	April 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 20, 2026	April 16, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 10, 2026	April 10, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 09, 2026	March 05, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 06, 2026	April 16, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 02, 2026	March 02, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 19, 2026	December 31, 2025	2025	View Filing

Showing 1 to 10 of 633 filings

Related Guides

Blog Categories

Continue your HUM research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.